Optimising trial designs to identify appropriate antibiotic treatment durations

被引:0
|
作者
Koen B. Pouwels
Mo Yin
Christopher C. Butler
Ben S. Cooper
Sarah Wordsworth
A. Sarah Walker
Julie V. Robotham
机构
[1] University of Oxford,Health Econonomics Research Centre, Nuffield Department of Population Health
[2] Modelling and Economics Unit,Department of Health Sciences, Global Health
[3] National Infection Service,Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine
[4] Public Health England,Division of infectious disease
[5] University Medical Centre Groningen,Nuffield Department of Primary Care Health Sciences
[6] University of Groningen,Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health
[7] Mahidol University,National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital
[8] University Medicine Cluster,undefined
[9] National University Hospital,undefined
[10] The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford,undefined
[11] University of Oxford,undefined
[12] University of Oxford,undefined
[13] University of Oxford,undefined
[14] MRC Clinical Trials Unit at University College London,undefined
来源
BMC Medicine | / 17卷
关键词
Antimicrobial resistance; Design; Randomised trial; Duration of therapy; Antibiotics; Bayesian; Frequentist;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Optimising trial designs to identify appropriate antibiotic treatment durations
    Pouwels, Koen B.
    Yin, Mo
    Butler, Christopher C.
    Cooper, Ben S.
    Wordsworth, Sarah
    Walker, A. Sarah
    Robotham, Julie, V
    BMC MEDICINE, 2019, 17 (1)
  • [2] Optimising lupus drug trial designs
    Morand, Eric
    LUPUS SCIENCE & MEDICINE, 2023, 10 (SUPPL_2): : A17 - A17
  • [3] Shortening Antibiotic Treatment Durations for Bacteremia
    Daneman, Nick
    Fowler, Robert A.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (07) : 1099 - 1100
  • [4] Appropriate antibiotic treatment for pneumonia
    Rello, J
    Diaz, E
    Bodi, M
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) : 1313 - 1314
  • [5] Identifying appropriate phase II trial designs
    Sarah R Brown
    Trials, 12 (Suppl 1)
  • [6] Optimising the antibiotic treatment of uncomplicated acute appendicitis: a protocol for a multicentre randomised clinical trial (APPAC II trial)
    Haijanen, J.
    Sippola, S.
    Gronroos, J.
    Rautio, T.
    Nordstrom, P.
    Rantanen, T.
    Aarnio, M.
    Ilves, I.
    Hurme, S.
    Marttila, H.
    Virtanen, J.
    Mattila, A.
    Paajanen, H.
    Salminen, P.
    BMC SURGERY, 2018, 18
  • [7] Optimising the antibiotic treatment of uncomplicated acute appendicitis: a protocol for a multicentre randomised clinical trial (APPAC II trial)
    J. Haijanen
    S. Sippola
    J. Grönroos
    T. Rautio
    P. Nordström
    T. Rantanen
    M. Aarnio
    I. Ilves
    S. Hurme
    H. Marttila
    J. Virtanen
    A. Mattila
    H. Paajanen
    P. Salminen
    BMC Surgery, 18
  • [8] Benefit associated with appropriate antibiotic treatment
    Leibovici, Leonard
    Paul, Mical
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (10) : 1400 - 1400
  • [9] Appropriate antibiotic treatment for pneumonia -: Reply
    González, C
    Rubio, M
    Romero-Vivas, J
    Picazo, JJ
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) : 1314 - 1315
  • [10] Appropriate on-farm trial designs for precision farming
    Lowenberg-DeBoer, J
    Lambert, D
    Bongiovanni, R
    PRECISION AGRICULTURE, 2003, : 361 - 366